| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Executive Chair | Director | President And CEO
2 companies
White Marvin L serves as a Director at EBS and has filed Form 4s across 2 companies. Across recent SEC filings that breaks down to 4 buys and 7 sells. Those positions are worth an estimated $5K at current prices.
The biggest single holding is APVO (~$5K) as Executive Chair.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 11, 2024 | EBS Emergent Biosolutions Inc. | Director | Sell | 14,287 | $11.97 | $171,015.39 | -20.9% | -15.5% | -9.1% | |
| Jun 14, 2019 | APVO Aptevo Therapeutics Inc. | President And CEO | Buy | 50,000 | $0.88 | $44,000.00 | +20.5% | - | - | |
| May 20, 2019 | APVO Aptevo Therapeutics Inc. | President And CEO | Buy | 30,000 | $0.81 | $24,300.00 | +14.0% | - | - | |
| May 14, 2019 | APVO Aptevo Therapeutics Inc. | President And CEO | Buy | 10,000 | $0.78 | $7,800.00 | +4.9% | - | - | |
| Dec 4, 2018 | APVO Aptevo Therapeutics Inc. | President And CEO | Buy | 10,000 | $2.38 | $23,800.00 | +5.2% | - | - | |
| Mar 19, 2018 | APVO Aptevo Therapeutics Inc. | President And CEO | Sell | 100,000 | $2.93 | $293,000.00 | -37.5% | - | - | |
| Mar 7, 2016 | EBS Emergent Biosolutions Inc. | Director | Sale+OE | 33,134 | $35.42 | $1,173,606.28 | -52.2% | - | - |